The increasing global cancer burden, with an estimated 20 million new cases and 9.7 million deaths globally in 2022 with projections indicating a 77% increase in incidence by 2050 and the limitations of current treatments, which are exemplified by the fact that despite advancements in cancer detection, treatment and supportive care, survival outcomes remain suboptimal for many patients, together highlight an unmet need for novel therapeutic agents that are both effective and safe (1)
Theyre used to improve energy levels, boost immunity, and support recovery from fatigue, dehydration, and chronic illness
Graves' disease and mental disorders
Blood-brain barrier profile pretreatment is associated with hemorrhagic transformation after endovascular reperfusion
in children, the recommended dose is 10 to 15 mg/kg every 4 to 6 hours, not to exceed 50 to 70 mg/kg in 24 hours
It plays a key role in reducing inflammation and oxidative stress in the injured area, further supporting the healing process